(Q47573959)

4 February 2018

title

Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries (English)

1 reference

4 February 2018

0 references

0 references

6

Maarten J Postma

1 reference

4 February 2018

author name string

Hong-Anh T Tu

1

1 reference

4 February 2018

Mark H Rozenbaum

2

1 reference

4 February 2018

Peter C Coyte

3

1 reference

4 February 2018

Shu Chuen Li

4

1 reference

4 February 2018

Herman J Woerdenbag

5

1 reference

4 February 2018

language of work or name

English

0 references

publication date

23 November 2011

1 reference

4 February 2018

published in

Vaccine

1 reference

4 February 2018

volume

30

1 reference

4 February 2018

issue

8

1 reference

4 February 2018

page(s)

1521-1528

1 reference

4 February 2018

Global Illness and Deaths Caused by Rotavirus Disease in Children

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

Global mortality associated with rotavirus disease among children in 2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

Cost-effectiveness of Rotavirus vaccination in Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

The burden of rotavirus diarrhea in Khanh Hoa Province, Vietnam: baseline assessment for a rotavirus vaccine trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

An update to “The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe”

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

Validity of reported vaccination coverage in 45 countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

The cost-effectiveness of rotavirus vaccination in Malawi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

Cost-effectiveness analysis of routine rotavirus vaccination in Brazil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

Economic evaluation of a routine rotavirus vaccination programme in Indonesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

Cost of immunization with a locally produced, oral cholera vaccine in Viet Nam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.052

10.1016/J.VACCINE.2011.11.052

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

release_smkocwyvmzgadfm2tyodje7ufu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/smkocwyvmzgadfm2tyodje7ufu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

4 February 2018